Full Text View
Tabular View
No Study Results Posted
Related Studies
Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease
This study has been completed.
Study NCT00069316   Information provided by National Institutes of Health Clinical Center (CC)

First Received on September 22, 2003.   Last Updated on March 2, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
West Nile Virus
Additional conditions recognized in this trial
Virus Diseases
Interventions listed in this trial
Omr-IgG-am
Additional drug interventions recognized in this trial
Immunoglobulins, Intravenous
Rho(D) Immune Globulin
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institutes of Health Clinical Center (CC)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services